Related references
Note: Only part of the references are listed.Drug discovery in tuberculosis. New drug targets and antimycobacterial agents
Andre Campanico et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, synthesis, and biological evaluation of m-amidophenol derivatives as a new class of antitubercular agents
Niu-niu Zhang et al.
MEDCHEMCOMM (2018)
Gene mutations in Mycobacterium tuberculosis: Multidrug-resistant TB as an emerging global public health crisis
Rahul Mishra et al.
TUBERCULOSIS (2015)
Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents
Jian Tang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Engineering More Stable, Selectable Marker-Free Autoluminescent Mycobacteria by One Step
Feng Yang et al.
PLOS ONE (2015)
Solvent-Free Buchwald-Hartwig Reaction of Aryl and Heteroaryl Halides with Secondary Amines
Maxim A. Topchiy et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2014)
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
Kevin Pethe et al.
NATURE MEDICINE (2013)
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
Katherine A. Sacksteder et al.
FUTURE MICROBIOLOGY (2012)
Autoluminescent Mycobacterium tuberculosis for Rapid, Real-Time, Non-Invasive Assessment of Drug and Vaccine Efficacy
Tianyu Zhang et al.
PLOS ONE (2012)
The challenge of new drug discovery for tuberculosis
Anil Koul et al.
NATURE (2011)
Global tuberculosis drug development pipeline: the need and the reality
Zhenkun Ma et al.
LANCET (2010)
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice
Makoto Matsumoto et al.
PLOS MEDICINE (2006)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover et al.
NATURE (2000)
Share Paper
